Cargando…
Identification of new aptamer BC-3 targeting RPS7 from rapid screening for bladder carcinoma
Aptamers, short single DNA or RNA oligonucleotides, have shown immense application potential as molecular probes for the early diagnosis and therapy of cancer. However, conventional cell-SELEX technologies for aptamer discovery are time-consuming and laborious. Here we discovered a new aptamer BC-3...
Autores principales: | Liu, Yunyi, Li, Juan, Ou, Hailong, Qi, Dan, Hu, Bei, Xu, Yuxi, Hu, Jian, Xiong, Yi, Xia, Luling, Huang, Jason H., Hu, Xiaoxiao, Wu, Erxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363591/ https://www.ncbi.nlm.nih.gov/pubmed/37492709 http://dx.doi.org/10.1016/j.gendis.2022.07.002 |
Ejemplares similares
-
DNA aptamer S11e recognizes fibrosarcoma and acts as a tumor suppressor
por: Liu, Yunyi, et al.
Publicado: (2021) -
Development of a DNA Aptamer for Screening Neisseria meningitidis Serogroup B by Cell SELEX
por: Mirzakhani, Kimia, et al.
Publicado: (2018) -
Aptamer-functionalized hydrogels promote bone healing by selectively recruiting endogenous bone marrow mesenchymal stem cells
por: Gong, Jiang-Shan, et al.
Publicado: (2023) -
Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells
por: Jafari, Reza, et al.
Publicado: (2019) -
Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022)